![Innocutis Holdings LLC Licenses Sitavig from BioAlliance Pharma | Sitavig ( acyclovir), 50mg Muco-Adhesive Buccal Tablets Innocutis Holdings LLC Licenses Sitavig from BioAlliance Pharma | Sitavig ( acyclovir), 50mg Muco-Adhesive Buccal Tablets](https://sitavig.com/wp-content/uploads/2014/03/sitavig-bg_narrow-1080x330.jpg)
Innocutis Holdings LLC Licenses Sitavig from BioAlliance Pharma | Sitavig ( acyclovir), 50mg Muco-Adhesive Buccal Tablets
Innocutis Introduces Sitavig® 50mg (ACYCLOVIR) Muco-Adhesive Buccal Tablet For Relief From Herpes Labialis (Cold Sores)
![Current status and future of delivery systems for prevention and treatment of infections in the oral cavity | SpringerLink Current status and future of delivery systems for prevention and treatment of infections in the oral cavity | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13346-021-00961-2/MediaObjects/13346_2021_961_Figa_HTML.png)
Current status and future of delivery systems for prevention and treatment of infections in the oral cavity | SpringerLink
![Pragmatic and Profound Benefits of Acyclovir Buccal Adhesive Tablets - JDDonline - Journal of Drugs in Dermatology Pragmatic and Profound Benefits of Acyclovir Buccal Adhesive Tablets - JDDonline - Journal of Drugs in Dermatology](http://dl.jddonline.com/articleimages/article_3022/table1.png)